Patents by Inventor Andrea Giuliani

Andrea Giuliani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8877738
    Abstract: The present invention relates to monomeric and multimeric peptidic compounds which have antipathogenic, in particular antiviral or/and antibacterial activity. In a preferred aspect, the peptide compounds of the invention have an activity in respect of a broad spectrum of viruses, both DNA and RNA viruses, irrespective of whether they possess virus envelope or not. Further, the present invention refers to compositions comprising said peptidic compounds for medical use, i.e. for the treatment or prevention of pathogenic, in particular viral or/and bacterial infections.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: November 4, 2014
    Assignee: Spiderbiotech S.r.L.
    Inventors: Andrea Giuliani, Giovanna Pirri, Lorena Pizzuto, Santo Landolfo, Giorgio Gribaudo, David Lembo, Davide Gibellini
  • Patent number: 8785399
    Abstract: The present invention relates to monomeric and multimeric peptidic compounds which have antimicrobial activity, particularly against Gram-positive and Gram-negative bacteria. Further, the present invention refers to compositions comprising said peptidic compounds for medical use, for use as a disinfectant and/or detergent or for use as a preservative.
    Type: Grant
    Filed: June 2, 2009
    Date of Patent: July 22, 2014
    Assignee: Spiderbiotech S.R.A.
    Inventors: Andrea Giuliani, Giovanna Pirri, Silvia Fabiole Nicoletto
  • Patent number: 8268961
    Abstract: Antibacterial peptides and their multimeric analogues, with a wide range of action and low haemolytic activity are described. In particular, the peptide molecules exhibit a high antimicrobial activity against numerous bacterial species, with reduced cytotoxicity and a low haemolysis rate. The molecules of the invention are advantageously usable as therapeutic agents and coadjutants against infections caused by strains that are resistant to common antibiotics.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: September 18, 2012
    Assignee: Universita Degli Studi di Siena
    Inventors: Luisa Bracci, Andrea Giuliani, Alessandro Pini, Paolo Neri
  • Publication number: 20120121623
    Abstract: The present invention relates to monomeric and multimeric peptidic compounds which have antipathogenic, in particular antiviral or/and antibacterial activity. In a preferred aspect, the peptide compounds of the invention have an activity in respect of a broad spectrum of viruses, both DNA and RNA viruses, irrespective of whether they possess virus envelope or not. Further, the present invention refers to compositions comprising said peptidic compounds for medical use, i.e. for the treatment or prevention of pathogenic, in particular viral or/and bacterial infections.
    Type: Application
    Filed: August 5, 2010
    Publication date: May 17, 2012
    Applicant: SPIDERBIOTCH S.r.L.
    Inventors: Andrea Giuliani, Giovanna Pirri, Lorena Pizzuto, Santo Landolfo, Giorgio Gribaudo, David Lembo, Davide Gibellini
  • Publication number: 20110077192
    Abstract: The present invention relates to monomeric and multimeric peptidic compounds which have antimicrobial activity, particularly against Gram-positive and Gram-negative bacteria. Further, the present invention refers to compositions comprising said peptidic compounds for medical use, for use as a disinfectant and/or detergent or for use as a preservative.
    Type: Application
    Filed: June 2, 2009
    Publication date: March 31, 2011
    Applicant: SPIDERBIOTECH S.R.L.
    Inventors: Andrea Giuliani, Giovanna Pirri, Silvia Fabiole Nicoletto
  • Publication number: 20090053151
    Abstract: Antibacterial peptides and their multimeric analogues, with a wide range of action and low haemolytic activity are described. In particular, the peptide molecules exhibit a high antimicrobial activity against numerous bacterial species, with reduced cytotoxicity and a low haemolysis rate. The molecules of the invention are advantageously usable as therapeutic agents and coadjutants against infections caused by strains that are resistant to common antibiotics.
    Type: Application
    Filed: July 13, 2005
    Publication date: February 26, 2009
    Inventors: Luisa Bracci, Andrea Giuliani, Alessandro Pini, Paolo Neri